Morgan Stanley Maintains Equal-Weight on Moderna, Raises Price Target to $200

Benzinga · 1d ago
Morgan Stanley analyst Terence Flynn maintains Moderna (NASDAQ:MRNA) with a Equal-Weight and raises the price target from $95 to $200.